Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9927044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene*

  1998cited by this paper
• A survey of 178 NF-Y binding CCAAT boxes.

  1998cited by this paper
• An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining.

  1997cited by this paper
• Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.

  1997cited by this paper
• Nuclear translocation of the Y‐box binding protein by ultraviolet irradiation

  1997cited by this paper
• Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.

  1996cited by this paper
• Analysis of Incision Sites Produced by Human Cell Extracts and Purified Proteins during Nucleotide Excision Repair of a 1,3-Intrastrand d(GpTpG)-Cisplatin Adduct (*)

  1996cited by this paper
• The General Transcription-Repair Factor TFIIH Is Recruited to the Excision Repair Complex by the XPA Protein Independent of the TFIIE Transcription Factor (*)

  1995cited by this paper
• Cisplatin and DNA repair in cancer chemotherapy.

  1995influential reference
• Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

  1994influential reference
• Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

  1994cited by this paper
• Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA.

  1993influential reference
• Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.

  1993cited by this paper
• A signature for the HMG‐1 box DNA‐binding proteins

  1993cited by this paper
• Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.

  1992cited by this paper
• The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man.

  1992cited by this paper
• Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

  1992cited by this paper
• DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs.

  1991cited by this paper
• High mobility group proteins 1 and 2 function as general class II transcription factors.

  1990cited by this paper
• Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

  1988cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension

  2024cites this paper
• Holistic anti-tumor resistance mechanism of YBX1 and its potential as a chemoresistance target in pancreatic ductal adenocarcinoma

  2023cites this paper
• YB-1 activating cascades as potential targets in KRAS-mutated tumors

  2023cites this paper
• Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives

  2022cites this paper
• Role of YB-1 in Regulation of Poly(ADP-Ribosylation) Catalyzed by Poly(ADP-Ribose) Polymerases

  2022cites this paper
• The C-Terminal Domain of Y-Box Binding Protein 1 Exhibits Structure-Specific Binding to Poly(ADP-Ribose), Which Regulates PARP1 Activity

  2022cites this paper
• Y-box Binding Protein 1: Looking Back to the Future

  2022cites this paper
• Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target

  2022cites this paper
• LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer

  2022cites this paper
• YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy

  2022cites this paper
• Long noncoding RNA HOTAIR interacts with Y-Box Protein-1 (YBX1) to regulate cell proliferation

  2021cites this paper
• MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

  2021cites this paper
• MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis

  2021cites this paper
• Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control

  2020cites this paper
• DNADamage

  2020cites this paper
• Y box binding protein 1 (YB-1) oncoprotein at the hub of DNA proliferation, damage and cancer progression.

  2020cites this paper
• YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms

  2020cites this paper
• Proteomic analysis of cisplatin- and oxaliplatin-induced phosphorylation in proteins bound to Pt-DNA adducts.

  2020cites this paper
• Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls

  2020cites this paper
• Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1

  2020cites this paper
• Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer

  2019cites this paper
• Effects of Y Box Binding Protein-1 in Progression and Prognosis of Cholangiocarcinoma

  2019cites this paper
• SWI/SNF complex subunit BAF60a represses hepatic ureagenesis through a crosstalk between YB-1 and PGC-1α

  2019cites this paper
• Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas

  2019cites this paper
• Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

  2019cites this paper
• Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus

  2019cites this paper
• Evaluation of YB-1 transcriptional factor, DNA glycosylase hNTH1 and human topoisomerase I functions in relation to drug resistance and DNA repair mechanisms

  2018cites this paper
• At the Interface of Three Nucleic Acids: The Role of RNA-Binding Proteins and Poly(ADP-ribose) in DNA Repair

  2017cites this paper
• Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.

  2017cites this paper
• Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target

  2017influential citation
• Interaction network analysis of YBX1 in four adenocarcinomas for identification of therapeutic targets

  2017cites this paper
• The effect of the dengue non-structural 1 protein expression over the HepG2 cell proteins in a proteomic approach.

  2017cites this paper
• Disrupting Y-Box-Binding Protein 1 Function Using OSU-03012 Prevents Endometriosis Progression in In Vitro and In Vivo Models

  2017cites this paper
• Annexin A2 and alpha actinin 4 expression correlates with metastatic potential of primary endometrial cancer.

  2017cites this paper
• High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma

  2016cites this paper
• Uncoupling of EGFR–RAS signaling and nuclear localization of YBX1 in colorectal cancer

  2016cites this paper
• Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1

  2016cites this paper
• Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

  2016cites this paper
• Structure prediction and docking-based molecular insights of human YB-1 and nucleic acid interaction

  2016cites this paper
• Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme

  2015cites this paper
• Y-box binding protein 1 (YB-1) promotes detection of DNA bulky lesions by XPC-HR23B factor

  2015cites this paper
• New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins

  2015cites this paper
• Characterising the phosphorylation of YB-1

  2015cites this paper
• Constitutive and functional expression of YB-1 in microglial cells.

  2015influential citation
• Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.

  2015cites this paper
• Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells

  2015cites this paper
• mRNA and DNA selection via protein multimerization: YB-1 as a case study

  2015cites this paper
• Thermodynamic characterization of the interaction between the human Y-box binding protein YB-1 and nucleic acids.

  2015cites this paper
• YB‐1 protein: functions and regulation

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma

  2014cites this paper
• Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction

  2014cites this paper
• YB-1 disrupts mismatch repair complex formation, interferes with MutSα recruitment on mismatch and inhibits mismatch repair through interacting with PCNA

  2014cites this paper
• Y-box binding protein 1--a prognostic marker and target in tumour therapy.

  2014cites this paper
• The structure, function and evolution of proteins that bind DNA and RNA

  2014cites this paper
• The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress

  2013cites this paper
• The role of Y-box binding protein 1 in prostate cancer

  2013cites this paper
• Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis

  2013influential citation
• The protein-protein interaction network of the human Sirtuin family.

  2013cites this paper
• The Ubiquitin Ligase \(CRL4^{Cdt2}\) Targets Thymine DNA Glycosylase for Destruction during DNA Replication and Repair

  2013cites this paper
• Tools and strategies for DNA damage interactome analysis.

  2013cites this paper
• TOX3 : a candidate breast cancer predisposition gene

  2012cites this paper
• Cloning, characterization and expression analysis of a cold shock domain family member YB-1 in turbot Scophthalmus maximus.

  2012cites this paper
• YB-1: Functional Analysis of a Potential Serum Marker for Neuroblastoma

  2012cites this paper
• Surmounting Chemoresistance by Targeting the Y‐Box Binding Protein‐1

  2012cites this paper
• Effect of the multifunctional proteins RPA, YB‐1, and XPC repair factor on AP site cleavage by DNA glycosylase NEIL1

  2012cites this paper
• Expression of Y-Box-binding protein 1 in Chinese patients with breast cancer

  2012cites this paper
• Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells.

  2012cites this paper
• Principles of protein nucleic acid : recognition on the examples of the ribosomal protein L1 and the cold shock domain of YB-1 protein

  2012cites this paper
• Expression and regulation of cold shock proteins in inflammatory kidney and liver diseases

  2012cites this paper
• Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.

  2012cites this paper
• Expression analysis of transcription factors CTCF ( CCCTC- binding factor), BORIS (Brother of the Regulator Imprinted Sites) and YB-1 (Y- box binding factor 1) in osteosarcoma and glioma cell lines: Physical Interaction of CTCF~YB-1 in vivo.

  2012cites this paper
• YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction, and HER2 amplification

  2011cites this paper
• NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines

  2011cites this paper
• An integrative approach to identify YB‐1‐interacting proteins required for cisplatin resistance in MCF7 and MDA‐MB‐231 breast cancer cells

  2011cites this paper
• Identification of Genes Involved in Hematopoietic Stem Cell Differentiation and Leukemia Differentiation and Leukemia

  2011influential citation
• Y-box-binding protein 1 (YB-1) and its functions

  2011cites this paper
• Interplay between Y-box-binding protein 1 (YB-1) and poly(A) binding protein (PABP) in specific regulation of YB-1 mRNA translation

  2011cites this paper
• Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth.

  2011cites this paper
• Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines

  2011cites this paper
• Forced Expression of ZNF143 Restrains Cancer Cell Growth

  2011cites this paper
• FOXK2 transcription factor is a novel G/T-mismatch DNA binding protein.

  2010cites this paper
• The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.

  2010cites this paper
• The N-Terminal Domain of Y-Box Binding Protein-1 Induces Cell Cycle Arrest in G2/M Phase by Binding to Cyclin D1

  2010cites this paper
• Analyse des interactions ADN lésé / protéines : Optimisations méthodologiques et applications aux dommages de l'ADN engendrés par les dérivés du platine

  2010cites this paper
• Comparison of structure, function and regulation of plant cold shock domain proteins to bacterial and animal cold shock domain proteins.

  2010cites this paper
• Mitochondrial helicases and mitochondrial genome maintenance.

  2010cites this paper
• Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

  2010cites this paper
• Novel DNA mismatch-repair activity involving YB-1 in human mitochondria.

  2009cites this paper
• Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA

  2009cites this paper
• Photoaffinity Isolation and Identification of Proteins in Cancer Cell Extracts that Bind to Platinum‐Modified DNA

  2009cites this paper
• Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.

  2009cites this paper
• Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer

  2009cites this paper
• Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment

  2009cites this paper
• Characterization of cold shock domain proteins and SUMOylation system from Oryza sativa

  2009cites this paper
• Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.

  2009cites this paper
• Mechanism of Strand-Specific Smooth Muscle α -Actin Enhancer Interaction by Purine-Rich Element Binding Protein B (Pur β ) †

  2009cites this paper
• Mechanism of strand-specific smooth muscle alpha-actin enhancer interaction by purine-rich element binding protein B (Purbeta).

  2009cites this paper
• Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.

  2009cites this paper
• Inhibition of transcription by platinum antitumor compounds.

  2009cites this paper